Sara Bonstein

Insider Reports History

Location
Brudgewater, NJ
Signature
/s/ Sara Bonstein, by Michael A. Smith as Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sara Bonstein:

Company Role Class Num Shares Value Price $ Report Date Ownership
INSMED Inc Chief Financial Officer Common Stock 80,506 $14,021,730 $174.17 08 Jan 2026 Direct
INSMED Inc Chief Financial Officer Stock Option (right to buy) 31,280 $654,246 $20.49 02 Jan 2026 Direct
Xilio Therapeutics, Inc. Director Stock Option (right to buy) 31,000 11 Jun 2025 Direct
scPharmaceuticals Inc. Director Stock Option (Right to Buy) 0 07 Oct 2025 Direct

Insider Reports Filed by Sara Bonstein

Symbol Company Period Transactions Value $ Form Type Role Filing Time
INSM INSMED Inc 06 Jan 2026 3 -$808,733 4 Chief Financial Officer 08 Jan 2026, 17:21
INSM INSMED Inc 02 Jan 2026 3 $0 4 Chief Financial Officer 06 Jan 2026, 16:08
SCPH scPharmaceuticals Inc. 07 Oct 2025 3 $0 4 Director 07 Oct 2025, 16:30
INSM INSMED Inc 21 Jul 2025 10 -$4,529,383 4 Chief Financial Officer 23 Jul 2025, 16:35
INSM INSMED Inc 07 Jul 2025 10 -$4,320,687 4 Chief Financial Officer 09 Jul 2025, 16:18
INSM INSMED Inc 23 Jun 2025 6 -$4,961,610 4 Chief Financial Officer 25 Jun 2025, 16:18
XLO Xilio Therapeutics, Inc. 11 Jun 2025 1 $0 4 Director 12 Jun 2025, 16:36
INSM INSMED Inc 10 Jun 2025 10 -$4,285,140 4 Chief Financial Officer 12 Jun 2025, 16:19
SCPH scPharmaceuticals Inc. 03 Jun 2025 1 $0 4 Director 05 Jun 2025, 16:49
INSM INSMED Inc 03 Jun 2025 1 -$112,898 4 Chief Financial Officer 04 Jun 2025, 17:36
INSM INSMED Inc 15 May 2025 2 $0 4 Chief Financial Officer 19 May 2025, 17:06
INSM INSMED Inc 13 May 2025 2 -$708,681 4 Chief Financial Officer 15 May 2025, 16:29
INSM INSMED Inc 18 Feb 2025 2 -$1,471,394 4 Chief Financial Officer 20 Feb 2025, 16:52
INSM INSMED Inc 11 Feb 2025 2 -$1,465,680 4 Chief Financial Officer 13 Feb 2025, 17:09
INSM INSMED Inc 05 Feb 2025 2 -$2,296,751 4 Chief Financial Officer 07 Feb 2025, 17:10
INSM INSMED Inc 07 Jan 2025 5 -$392,602 4 Chief Financial Officer 10 Jan 2025, 18:45
XLO Xilio Therapeutics, Inc. 14 Jun 2024 1 $0 4 Director 17 Jun 2024, 16:30
SCPH scPharmaceuticals Inc. 11 Jun 2024 1 $0 4 Director 13 Jun 2024, 17:00
INSM INSMED Inc 28 May 2024 26 -$5,659,148 4 Chief Financial Officer 30 May 2024, 17:41
INSM INSMED Inc 13 May 2024 3 -$280,748 4 Chief Financial Officer 15 May 2024, 16:32
INSM INSMED Inc 09 Jan 2024 1 -$131,222 4 Chief Financial Officer 11 Jan 2024, 16:07
INSM INSMED Inc 04 Jan 2024 2 $0 4 Chief Financial Officer 05 Jan 2024, 17:27
INSM INSMED Inc 22 Dec 2023 1 -$395,970 4 Chief Financial Officer 22 Dec 2023, 16:03
XLO Xilio Therapeutics, Inc. 12 Jun 2023 1 $0 4 Director 13 Jun 2023, 16:30
SCPH scPharmaceuticals Inc. 06 Jun 2023 1 $0 4 Director 08 Jun 2023, 16:15
INSM INSMED Inc 15 May 2023 2 -$72,390 4 Chief Financial Officer 17 May 2023, 16:09
INSM INSMED Inc 11 May 2023 3 $0 4 Chief Financial Officer 15 May 2023, 16:08
INSM INSMED Inc 10 Jan 2023 1 -$51,769 4 Chief Financial Officer 12 Jan 2023, 15:08
INSM INSMED Inc 05 Jan 2023 3 $0 4 Chief Financial Officer 06 Jan 2023, 15:17
XLO Xilio Therapeutics, Inc. 15 Jun 2022 1 $0 4 Director 17 Jun 2022, 16:30
SCPH scPharmaceuticals Inc. 14 Jun 2022 1 $0 4 Director 15 Jun 2022, 16:30
INSM INSMED Inc 16 May 2022 1 -$26,525 4 Chief Financial Officer 18 May 2022, 16:10
INSM INSMED Inc 11 May 2022 2 $0 4 Chief Financial Officer 13 May 2022, 18:12
INSM INSMED Inc 11 Jan 2022 1 -$28,977 4 Chief Financial Officer 13 Jan 2022, 15:41
INSM INSMED Inc 06 Jan 2022 2 $0 4 Chief Financial Officer 10 Jan 2022, 16:08
XLO Xilio Therapeutics, Inc. 21 Oct 2021 0 $0 3 Director 21 Oct 2021, 20:45
SCPH scPharmaceuticals Inc. 08 Jun 2021 1 $0 4 Director 10 Jun 2021, 16:45
INSM INSMED Inc 12 May 2021 2 $0 4 Chief Financial Officer 14 May 2021, 17:07